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ABSTRACT
Objectives To compare dementia prevalence and how it 
varies by socioeconomic status (SES) across the USA and 
England.
Design Population- based comparative study.
Setting Non- Hispanic whites aged over 70 population in 
the USA and England.
Participants Data from the Health and Retirement Study 
and the English Longitudinal Study of Ageing, which are 
harmonised, nationally representative panel studies. The 
sample includes 5330 and 3147 individuals in the USA and 
England, respectively.
Main outcome measures Between country differences in 
age- gender standardised dementia prevalence, across the 
SES gradient. Dementia prevalence was estimated in each 
country using an algorithm based on an identical battery of 
demographic, cognitive and functional measures.
Results Dementia prevalence is higher among the 
disadvantaged in both countries, with the USA being 
more unequal according to four measures of SES. Overall 
prevalence was lower in England at 9.7% (95% CI 8.9% to 
10.6%) than the USA at 11.2% (95% CI 10.6% to 11.8%), 
a difference of 1.4 percentage points (pp) (p=0.0055). 
Most of the between country difference is driven by the 
bottom of the SES distribution. In the lowest income decile 
individuals in the USA had 7.3 pp (p<0.0001) higher 
prevalence than in England. Once past health factors and 
education were controlled for, most of the within country 
inequalities disappeared; however, the cross- country 
difference in prevalence for those in lowest income decile 
remained disproportionately high.
Conclusions There is inequality in dementia prevalence 
according to income, wealth and education in both the 
USA and England. England has lower dementia prevalence 
and a less steep SES gradient. Most of the cross- country 
difference is concentrated in the lowest SES group, which 
provides evidence that disadvantage in the USA is a 
disproportionately high risk factor for dementia.
INTRODUCTION
Dementia, a severe and irreversible decline 
in memory and other cognitive functions, is a 
major and increasing global health challenge. 
It is the fifth leading cause of death globally 
and is one of the most common comorbid-
ities for COVID- 19 morbidity.1 2 It results in 
large social and economic costs.3 4
Americans are more likely to be in poor 
health than their English counterparts in 
multiple dimensions, including heart disease 
and diabetes.5 These differences are large 
along all points of the socioeconomic status 
(SES) gradient, although the gradient is 
generally steeper in the USA. While the SES 
gradient for many diseases has been well 
established,6–8 only a few studies have focused 
specifically on dementia.9 10 The available 
evidence is summarised in online supple-
mental table A1. The evidence of the SES 
gradient for dementia is also less clear, as in 
England while a strong association has been 
established between wealth and dementia 
incidence, the same was not observed for 
education level.11
The Global Burden of Disease Study (GBD) 
reported that in 2017 among those aged over 
70, the USA had a lower overall prevalence 
of dementia at 7.89% compared with the UK 
Strengths and limitations of this study
 ► This is the first study to compare dementia preva-
lence across countries using the same survey meth-
odology and the exact same measure of dementia. 
The surveys have similar sample selection and 
questionnaire design. We standardise our estimates 
by age and gender to the English population aged 
over 70 in 2016. Any differences in overall preva-
lence across the two countries should represent true 
differences.
 ► We measure the socioeconomic status (SES) gradi-
ent of dementia across four different measures of 
SES: income; education; wealth and non- housing 
wealth.
 ► Dementia disproportionately affects the most disad-
vantaged in both countries, although the gradient is 
steeper in the USA according to all four measures 
of SES.
 ► We do not ascertain dementia directly but predict 
cases using a common battery of measures in 
English Longitudinal Study of Ageing and Health and 
Retirement Study. One of the SES measures, educa-
tion, is also used as a predictor of dementia.
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at 8.91%.12 However, the GBD has identified substantial 
heterogeneity in case- ascertainment methods throughout 
the dementia literature, resulting in location- specific 
inconsistencies and potentially biased cross- country 
comparisons. This has led to calls for analyses with more 
consistent and comparable measures of dementia to 
inform policy makers, researchers and clinicians about 
global differences in dementia.13
In this study, we compared dementia prevalence in 
England and the USA among non- Hispanic whites aged 
70+, and how it varied across the SES gradient of each 
country. Location- specific inconsistencies caused by 
differences in diagnostic practices were not an issue in 
our study because we used an identical case definition 
for dementia, and the surveys in the analysis shared the 
same design and sampling techniques. More specifically, 
we used two large surveys, the US Health and Retire-
ment Study (HRS) and the English Longitudinal Study 
of Ageing (ELSA), that contain a battery of the same 
demographic, cognitive and functional measures, and 
we applied the same prediction algorithm in both coun-
tries to detect undiagnosed as well as diagnosed cases. 
We compared dementia prevalence within and across 
England and the USA using important indicators of SES, 




Data were extracted from the 2016 and earlier waves 
of the HRS and ELSA, which are nationally represen-
tative biennial surveys of the USA and English popula-
tions, respectively.14 15 Both the HRS and ELSA follow 
respondents longitudinally until death, with new cohorts 
entering to maintain population representativeness as the 
study sample gets older. The design of ELSA was based on 
the HRS, making the two surveys analogous, with both 
collecting data on health, ability, demographics, employ-
ment and wealth. In addition to measuring health condi-
tions and difficulties respondents have with Activities of 
Daily Living (ADLs) and Instrumental Activities of Daily 
Living (IADLs), sample members also have their cogni-
tive function assessed. A range of tests adapted from the 
Telephone Interview for Cognitive Status (TICS) have 
been carried out in HRS since 1996 and ELSA since 2014. 
If a sample member was unable to respond in person, a 
proxy respondent was asked questions about the respon-
dent’s change in memory. Both surveys have a high 
response rate, which is displayed in the online supple-
mental appendix A2. We describe these surveys in more 
detail in the online supplemental appendix.
Cohort description
Our samples are restricted to non- Hispanic whites over 
the age of 70 years old that live in the community or in 
nursing homes in 2016. This provides a study sample of 
5330 participants in the HRS and 3147 participants in 
ELSA. We restrict our sample to non- Hispanic whites 
to ensure estimates are comparable across countries. 
Summary statistics of both the raw and selected samples 
are displayed in online supplemental table A3 and A4, 
and specifications that include ethnic minorities are also 
displayed.
Patient and public involvement
No study participants were involved in setting the research 
question or outcome measures, nor were they involved in 
any other area of the design, implementation and analysis 
of the study. There are no direct plans to disseminate the 
results of the research to study participants.
Dementia case definition
The HRS included a detailed clinical substudy (ADAMS: 
Aging, Demographics and Memory Study) of 856 sample 
members aged 70+ who completed an in- depth in- home 
assessment of cognitive status conducted by experi-
enced teams at the Duke University Dementia Epidemi-
ology Research Center who diagnosed each participant 
as normal, cognitively impaired but not demented or 
demented.3 Data from ADAMS are regarded as the gold- 
standard dementia diagnoses against which to train 
algorithms to predict dementia.16 Hurd et al estimated 
separate ordered probit models in the ADAMS subsample 
for self- respondents and proxy- respondents to generate 
a predictive algorithm for cognitive status, based on the 
ADAMS diagnoses, for the whole HRS sample. The algo-
rithm uses a range of variables including demographic 
information, ADLs, IADLs, TICS questionnaire as well as 
the change in these variables across waves.3 Proxy respon-
dents had a separate predictive algorithm as they were 
asked a different set of questions from self- respondents, 
which included the short form of the Informant Ques-
tionnaire on Cognitive Decline in the Elderly (IQCODE). 
The use of a proxy to assess cognitive decline and 
dementia in elderly people is a recognised accepted stan-
dard method for identifying severe cognitive impairment 
and has been validated many times.17 Importantly, the 
same set of questions used in the Hurd et al algorithm is 
asked of self- respondents and proxy- respondents in both 
HRS and ELSA. Summary statistics for a variety of predic-
tors are displayed in online supplemental table A5.
We applied Hurd et al’s predictive algorithm to estimate 
the probably of dementia for those in the HRS sample in 
2016 and extended the prediction to the ELSA sample. 
The algorithm predicts the probability of dementia in the 
following year; therefore, we predicted dementia preva-
lence in 2017. Hurd et al’s predictive algorithm has been 
shown to have an accuracy (percentage correctly classi-
fied as demented or non- demented) of 94%, sensitivity of 
65% and a specificity of 98% in the estimation sample.16 
An in- depth discussion of the predictive algorithm proce-
dure can be found in the online supplemental appendix.
Non- response for people unable or unwilling to partic-
ipate in the survey is important when attempting to esti-
mate dementia prevalence across the population. While 
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attrition exists in both surveys, it is unlikely to significantly 
affect our estimates since among older ELSA and HRS 
respondents, there is no statistically significant correla-
tion between attrition and prior health or the SES indica-
tors of education, income and wealth.18
Measures of socioeconomic status
We considered four measures of SES: income; education; 
wealth and non- housing wealth. Income is measured as 
current household income from all sources. For educa-
tion, we used total years of schooling. Wealth is measured 
as the sum of all household reported savings, stocks, 
bonds, business wealth, other assets and the value of 
housing assets (eg, properties) after financial debt and 
mortgage debt has been subtracted. Non- housing wealth 
is the same measure as wealth but excludes housing assets 
and mortgage debt and therefore measures wealth that 
can be more easily converted to cash. Wealth and non- 
housing wealth are both measured from 4 years prior to 
minimise reverse causality, as medical expenses associated 
with dementia are high and may run down wealth.4 For 
each measure, we created a SES gradient by ranking indi-
viduals based on that measure. For income, wealth and 
non- housing wealth, we assigned everyone to a decile in 
their respective country. For education, we ranked indi-
viduals according to their number of years of schooling.
Statistical analysis
We created a pooled dataset of the two surveys. In our statis-
tical analysis, we used HRS and ELSA sampling weights to 
adjust for non- response and for the sampling design of 
the surveys. To make both within country estimates along 
the SES gradient and cross- country estimates directly 
comparable, estimates were age- gender standardised to 
the English population aged over 70 in 2016 using direct 
standardisation, categorising the population into 10 
groups: five age bands (70–74; 75–79; 80–84; 85–89 and 
90+) by gender. We estimated the prevalence of dementia 
in each country, their difference and compared the prev-
alence along the four SES gradients. For each estimate 
presented, we computed the corresponding 95% CI, 
and for any differences we computed the corresponding 
p values. For each SES factor, as well as estimating the 
age- gender standardised prevalence along the gradient, 
we calculated the Relative Index of Inequality (RII) and 
Slope Index of Inequality (SII) using generalised linear 
models (log binomial regression) with logarithmic and 
identity link functions, respectively. The RII can be inter-
preted as the relative likelihood of dementia prevalence 
of those in the lowest SES group compared with those in 
the highest, and the SII can be interpreted as the abso-
lute effect on dementia probability of moving from the 
lowest SES group to the highest.19 To assess whether any 
observed differences could be explained by disparities in 
past health risk factors across countries, we conditioned 
on a variety of risk factors and assessed how our estimates 
changed. Where possible, when conditioning on these 
factors, we used past health instead of current health 
to address the problem of reverse causality: that is, the 
problem that dementia may cause health problems such 
as low weight. Statistical analyses were performed using 
STATA software.
RESULTS
Table 1 shows the age- gender standardised prevalence 
of dementia for the aged over 70 white non- Hispanic 
population in both England and the USA. Dementia 
prevalence is lower in England at 9.7% (95% CI 8.9% to 
10.6%) than the USA at 11.2% (95% CI 10.6% to 11.8), 
a difference of 1.4 percentage points (pp) that is highly 
statistically significant (p=0.0055).
Table 1 also shows dementia prevalence for different 
SES groups, in terms of income, education, wealth and 
non- housing wealth. Regardless of the measure of the 
SES, there is a clear gradient in dementia prevalence, with 
the most disadvantaged groups in both England and the 
USA having higher dementia prevalence. The gradient is 
steeper in the USA and is driven by significantly higher 
dementia prevalence for those at the very bottom of the 
distribution. In the USA, those in the lowest income 
decile have a dementia prevalence of 18.7% (95% CI 
16.6% to 20.8%), which is considerably higher than in 
England, with a prevalence among those in the lowest 
decile of 11.4% (95% CI 8.9% to 13.9%). The difference 
is highly statistically significant (p<0.0001). For income 
deciles above the lowest, the difference across the two 
countries is much smaller and not statistically significant. 
This same general pattern is evident across the other 
measures of SES that we consider, although when using 
wealth, the difference between those in the bottom decile 
is not statistically significant.
Figure 1 presents the same dementia prevalence infor-
mation shown in table 1, but in graphical format. It also 
reports the SII for the four different measures of the 
SES for both countries. In both the USA and England, 
dementia is more prevalent among the more disadvan-
taged. The gradient tends to be steeper in the USA, 
corresponding to a larger (in absolute value) SII in the 
USA for each SES measure. For income, the SII is −0.062 
(95% CI −0.097 to −0.028) and −0.085 (95% CI −0.114 to 
−0.057) for England and the USA, respectively. The SIIs 
are not statistically different. If the lowest income decile 
is excluded, the SII for England becomes slightly steeper 
(−0.067 (95% CI −0.107 to −0.027)) whereas the SII for 
the USA becomes less steep than England (−0.060 (95% 
CI −0.093 to −0.027)).
Next, we attempted to understand the potential drivers 
of these gradients and the differences in the gradients 
across countries. We extended the analysis to account 
for cardiometabolic diseases (ie, diabetes, heart disease 
and stroke) and behaviours (ie, smoking and body mass 
index) as dementia risk factors.1 20 Previous research 
showed these factors to be more prevalent in the USA 
than England, especially among the most disadvan-
taged.5 Table 2 displays the percentage point difference 
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All 0.097 (0.089 to 0.106) 0.112 (0.106 to 0.118) 0.014 0.0055
Household income decile
  1 (lowest) 0.114 (0.089 to 0.139) 0.187 (0.166 to 0.208) 0.073 <0.0001
  2 0.113 (0.090 to 0.136) 0.141 (0.119 to 0.163) 0.028 0.090
  3 0.124 (0.097 to 0.151) 0.111 (0.095 to 0.127) −0.013 0.42
  4 0.099 (0.071 to 0.126) 0.118 (0.099 to 0.137) 0.019 0.26
  5 0.094 (0.072 to 0.116) 0.086 (0.069 to 0.102) −0.008 0.56
  6 0.098 (0.070 to 0.127) 0.108 (0.088 to 0.128) 0.010 0.59
  7 0.068 (0.042 to 0.093) 0.100 (0.078 to 0.122) 0.032 0.060
  8 0.083 (0.053 to 0.114) 0.082 (0.066 to 0.097) −0.002 0.92
  9 0.082 (0.041 to 0.122) 0.093 (0.071 to 0.116) 0.012 0.62
  10 (highest) 0.059 (0.035 to 0.083) 0.077 (0.052 to 0.103) 0.019 0.30
Years of schooling
  9 or fewer 0.128 (0.101 to 0.154) 0.190 (0.162 to 0.218) 0.062 0.0015
  10 0.095 (0.074 to 0.116) 0.137 (0.109 to 0.165) 0.042 0.018
  11 0.096 (0.077 to 0.115) 0.109 (0.080 to 0.139) 0.013 0.471
  12 0.071 (0.042 to 0.100) 0.124 (0.114 to 0.133) 0.053 0.0006
  13 0.061 (0.038 to 0.083) 0.116 (0.090 to 0.141) 0.055 0.0013
  14 or more 0.056 (0.039 to 0.073) 0.085 (0.076 to 0.093) 0.029 0.0031
Household wealth decile
  1 (lowest) 0.165 (0.132 to 0.198) 0.187 (0.162 to 0.211) 0.022 0.31
  2 0.117 (0.092 to 0.143) 0.149 (0.129 to 0.169) 0.031 0.061
  3 0.100 (0.073 to 0.127) 0.107 (0.091 to 0.122) 0.006 0.68
  4 0.093 (0.071 to 0.115) 0.115 (0.098 to 0.132) 0.022 0.12
  5 0.110 (0.085 to 0.134) 0.091 (0.077 to 0.106) −0.018 0.21
  6 0.080 (0.057 to 0.103) 0.089 (0.074 to 0.103) 0.008 0.55
  7 0.070 (0.046 to 0.094) 0.103 (0.084 to 0.123) 0.034 0.034
  8 0.092 (0.066 to 0.118) 0.089 (0.072 to 0.106) −0.003 0.85
  9 0.082 (0.048 to 0.116) 0.103 (0.084 to 0.123) 0.021 0.28
  10 (highest) 0.060 (0.038 to 0.081) 0.067 (0.051 to 0.084) 0.008 0.58
Household non- housing wealth decile
  1 (lowest) 0.136 (0.103 to 0.168) 0.201 (0.176 to 0.226) 0.065 0.0019
  2 0.109 (0.084 to 0.134) 0.137 (0.119 to 0.156) 0.029 0.074
  3 0.123 (0.095 to 0.151) 0.131 (0.111 to 0.150) 0.008 0.66
  4 0.096 (0.073 to 0.118) 0.101 (0.085 to 0.116) 0.005 0.71
  5 0.108 (0.082 to 0.134) 0.107 (0.091 to 0.123) −0.001 0.95
  6 0.093 (0.067 to 0.119) 0.086 (0.070 to 0.101) −0.007 0.64
  7 0.099 (0.072 to 0.125) 0.086 (0.070 to 0.102) −0.013 0.42
  8 0.078 (0.051 to 0.105) 0.090 (0.073 to 0.106) 0.011 0.49
  9 0.058 (0.036 to 0.081) 0.092 (0.074 to 0.111) 0.034 0.024
  10 (highest) 0.063 (0.043 to 0.084) 0.079 (0.062 to 0.095) 0.015 0.26
Sample includes non- Hispanic white population aged 70+ only. The sample size is 3147 participants in England and 5330 participants 
in the USA. All estimates are age- gender standardised to the overall 2016 aged 70+ white population in England. The difference is 
calculated as the prevalence in the USA minus prevalence in England. All deciles are calculated within country.
Overall prevalence and prevalence according to four measures of socioeconomic status.
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in dementia prevalence after we controlled for various 
measures of past health and behaviours. The results are 
split into three panels: the whole sample; the whole sample 
excluding those in the lowest income decile and the 
lowest income decile. As was shown in table 1, the differ-
ence in the prevalence of dementia between England and 
the USA was 1.43 pp (p=0.0055). Table 2 shows this differ-
ence declined to 0.894 pp (p=0.11) when we excluded 
the lowest income decile. Controlling for past health and 
behaviours modestly reduced this cross- country differ-
ence further: the difference declined by a maximum of 
19%. For the lowest income decile, controlling for past 
health and behaviour reduced the cross- country differ-
ence of 7.27 pp (p<0.0001) by a more substantial 33%.
In the online supplemental tables A6–A8, we inves-
tigated whether past health and behaviour explained 
the SES gradient within each country. We found that in 
England and the USA these factors accounted for most of 
the SES gradient, as shown in online supplemental figure 
A1. However, in the USA, prevalence in the lowest income 
decile remained disproportionately high.
Education has also been shown to be a risk factor 
for dementia. Table 1 shows that in both the USA and 
England, the less educated have higher dementia preva-
lence. Controlling for education increased the estimated 
difference across countries, from 1.43 pp to 2.82 pp, as can 
be seen in the online supplemental table A7. Education 
cannot explain these differences since the English have 
lower educational attainment.
In our main analysis, we exclude ethnic minorities, who 
have higher dementia prevalence and comprise a larger 
share of the USA than the English population. Including 
minorities increased the estimated difference across coun-
tries, from 1.43 pp to 2.42 pp, as can be seen in the online 
supplemental tables A9 and A10. This is largely caused by 
the high prevalence of dementia among minorities in the 
USA as displayed in online supplemental table A11.
DISCUSSION
Main findings
Using nationally representative samples of older indi-
viduals from England and the USA and applying the 
same algorithmic procedure to predict dementia in both 
samples, we showed that in both the USA and England 
dementia is more prevalent among the disadvantaged, 
and the SES gradient of dementia is steeper in the USA. 
The steeper gradient in the USA is largely driven by those 
in the lowest decile. In both countries, most of the SES 
gradient disappeared when we controlled for past health 
related factors, although prevalence for those in lowest 
income decile in the USA remained disproportionately 
high. If the lowest income decile is excluded from our 
sample the difference in dementia prevalence across the 
Figure 1 SES Gradient of Dementia, USA versus England, 2017, according to four measures of SES. Absolute and relative 
inequality shown with 95% CI. The points in this figure represent the mean age- gender standardised dementia prevalence for 
each country by SES, along with 95% CI for these predictions. The solid lines represent the fitted Slope Index of Inequality 
(SII: absolute inequality) for each country. The values of the SII and the corresponding Relative Index of Inequality (RII: relative 
inequality) are listed in the top right of each figure, with 95% CI in brackets. For education, individuals are ranked based on 
their years of schooling within each country, and as the USA has higher educational attainment, individuals with 14+ years 
of schooling are the 80th percentile of the US education distribution, but at the 90th percentile of the English educational 
distribution. SES, socioeconomic status.
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countries is statistically insignificant, and the remaining 
SES gradient of dementia is remarkably similar across 
countries.
While poorer individuals face a higher burden of 
dementia in both England and the USA, the extremely 
poor in the USA face a disproportionately high burden of 
dementia. Controlling for past health- related factors can 
explain some, but not all, of the cross- country difference. 
It can explain up to around one third of the difference 
for those in the lowest income decile. While past health 
factors such as adiposity and smoking are correlated with 
dementia, those in the lowest income decile in the USA 
do not smoke more or have higher body mass indexes 
(BMIs) than their English counterparts. Therefore, this 
cannot explain their disproportionately higher prev-
alence of dementia. Education also cannot explain the 
difference, as the US population is more educated at 
every income decile, and in fact the educational differ-
ence masks some of the underlying dementia risk differ-
ence between countries.
Adding minorities increased estimated dementia prev-
alence, especially in the USA, because dementia preva-
lence is higher among minorities, who comprise a higher 
share of the USA than the English population. This fits 
with prior research which showed dementia prevalence 
is higher for non- whites and Hispanics.20 21 We did not 
observe higher dementia prevalence among Hispanics 
and non- whites in the USA for those in relatively high 
socioeconomic groups.
Comparison with previous studies and how findings are an 
advance on current literature
Previous studies have shown cross- country variation in 
dementia prevalence. However, substantial heteroge-
neity in case- ascertainment methods across countries and 
studies makes interpreting any observed differences diffi-
cult. We believe this is the first study to compare dementia 
prevalence in England and the USA using the exact same 
measure of dementia, thus overcoming previous diffi-
culties in making comparisons across the two countries 
due differences in diagnostic practices and case defini-
tions. We also compared the SES gradient of dementia 
in both countries. While some studies have shown in 
both England and the USA those with lower education 
and less wealth have been found to have higher rates of 
dementia,4 9 11 22 23 there are no systematic comparative 
studies. We compared prevalence along the SES gradient 
using almost identical measures of income, wealth and 
education. Further, we standardised the cross- country 
comparison for age and gender, using the English over 
70 population as the standard population. We found that 
dementia prevalence is higher and more concentrated 
Table 2 Difference in prevalence of dementia, USA vs England, 2017
Whole sample
  Percentage point difference 1.43 1.34 1.15 1.21 1.18
  p value 0.0055 0.0091 0.025 0.020 0.034
  % Difference from baseline – −6% −19% −16% −17%
Excluding lowest income decile
  Percentage point difference 0.89 0.88 0.74 0.75 0.81
  p value 0.11 0.11 0.18 0.18 0.18
  % difference from baseline – −2% −17% −16% −10%
Lowest income decile
  Percentage point difference 7.27 6.14 5.45 5.93 4.85
  p value <0.0001 0.0003 0.002 0.0011 0.012
  % difference from baseline – −15% −25% −18% −33%
Control for
  Past cardiometabolic diseases ✓ ✓ ✓ ✓
  Past psychiatric conditions ✓ ✓ ✓
  Ever smoked ✓ ✓
  Past BMI ✓
Sample includes non- Hispanic white population aged 70+ only. The sample size is 3147 participants in England and 5330 participants in the 
USA. All estimates are age- gender standardised to the overall 2016 aged 70+ white population in England. The difference is calculated as the 
prevalence in the USA minus prevalence in England. Differences are displayed as percentage points. ‘Past Cardiometabolic Diseases’ and 
‘Past Psychiatric Conditions’ control for whether an individual says they had the conditions 4 years prior. ‘Cardiometabolic Diseases’ include 
diabetes, heart disease and stroke. ‘Smoking’ controls for whether an individual has ever smoked. ‘Past BMI’ includes dummy variables to 
control for whether an individual is classed as underweight, overweight or obese. BMI values are based on when an individual first entered the 
survey, which is at least 10 years prior.
Estimates of the between- country difference taking account of antecedent health status, smoking and degree of adiposity.
BMI, body mass index.
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among the poorest in the USA than England. Detailed 
disaggregation according to SES measures shows the 
true extent of the excess burden of dementia in the very 
poorest group in the USA.
We showed that risk factors for dementia such as 
cardiometabolic diseases, psychiatric conditions, high 
BMI, smoking have similar affects across countries. 
Accounting for these risk factors removes most of the 
SES gradient for both countries, but disproportionately 
high prevalence remains for the most disadvantaged in 
the USA.
Implications (wider interpretation)
Much research has shown that low- income Americans are 
more likely to be in poor health and die younger than 
their high- income counterparts.24 We show that these 
health differences also extend to dementia prevalence.
While risk factors contribute to higher prevalence 
among those who are more disadvantaged, those in the 
USA appear to have an undue burden that is caused by 
risk factors for which we cannot account. One possible 
explanation is differential access to healthcare. The NHS 
provides broadly equitable care according to education in 
the older population after accounting for health status.25 
In the USA, the poor often go uninsured, and although 
virtually every American aged 65 or older is eligible for 
Medicare, around 20% of Medicare beneficiaries health-
care must be financed out of pocket.26 The extent to 
which healthcare provision below and above aged 65 may 
account for the relative excess dementia burden in the 
USA is unclear.
The implications of our results are that interventions 
designed to attempt to prevent dementia should be 
targeted towards the most disadvantaged. This is espe-
cially true in the USA. As yet, we are unable to advocate 
specific measures as we do not yet understand the specific 
nature of disadvantage in respect to dementia risk.
Strengths and weaknesses of analysis
This study has a strong design. Results are directly compa-
rable across England and the USA. The same predictive 
algorithm was applied to both countries, addressing the 
problem of heterogeneity in case ascertainment which 
has affected the literature.1 13 Further, because ELSA and 
HRS share sample selection and questionnaire design, 
any differences in overall prevalence and SES gradients 
in prevalence across the two countries should represent 
true differences. In contrast to the Global Burden Disease 
study, we find higher dementia prevalence in the USA. 
Furthermore, we measured the SES gradient of dementia 
across four different measures of SES, with consistent 
results. Our work also highlights the usefulness of the 
standardised measure of dementia to allow for mean-
ingful comparisons across countries.
This study had three limitations. First, we do not 
ascertain dementia directly, but predict cases using a 
common battery of measures in ELSA and HRS. Impor-
tantly, Hurd’s prediction algorithm has high accuracy 
and although our case definition lacks a clinical point 
of reference in England, it is based on a detailed clinical 
substudy in the USA.16 Further, cross- cultural subjectivi-
ties in reporting of impairment severity are likely to be 
similar in the USA and England (see online supplemental 
table A5). It would be of great value for future work to 
use the Harmonized Cognitive Assessment Protocol data 
to provide a standard clinical point of reference to vali-
date and verify the cross- country dementia prevalence 
estimates.27 Second, education is one of the factors in the 
predictive algorithm for dementia and also one of our 
measures of SES. The dementia algorithm takes account 
of the well- documented correlation between education 
level and cognitive function in adult life. Nevertheless, 
we found substantial absolute and relative inequalities in 
dementia prevalence according to education level in the 
USA and UK. Education may be a successful approach 
for reducing dementia risk.28 Third, while we show risk 
factors explain a large proportion of the differences in 
dementia between the England and the USA—although 
cannot account for the difference in the lowest income 
decile—there are likely other unmeasured confounding 
factors that impact dementia prevalence which we do not 
observe.
CONCLUSION
Given the large social and economic costs of dementia, 
there is great value in understanding the scope and 
burden of dementia in the population along the SES 
gradient. This study indicates that more disadvantaged 
individuals face a higher burden of dementia and that 
the poorest individuals in the USA face a disproportion-
ately high burden. The high burden faced by these indi-
viduals can be partly but not fully explained by past health 
factors. We lacked data on other important possible 
contributing factors such as habitual drug use. Further 
research is needed to fully understand this issue using 
data from multiple sources.
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